Wild type p53 function in p53Y220C mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence

Journal of Experimental & Clinical Cancer Research : CR
Durai SundarRenu Wadhwa

Abstract

Tumor suppressor p53 protein is frequently mutated in a large majority of cancers. These mutations induce local or global changes in protein structure thereby affecting its binding to DNA. The structural differences between the wild type and mutant p53 thus provide an opportunity to selectively target mutated p53 harboring cancer cells. Restoration of wild type p53 activity in mutants using small molecules that can revert the structural changes have been considered for cancer therapeutics. We used bioinformatics and molecular docking tools to investigate the structural changes between the wild type and mutant p53 proteins (p53V143A, p53R249S, p53R273H and p53Y220C) and explored the therapeutic potential of Withaferin A and Withanone for restoration of wild type p53 function in cancer cells. Cancer cells harboring the specific mutant p53 proteins were used for molecular assays to determine the mutant or wild type p53 functions. We found that p53V143A mutation does not show any significant structural changes and was also refractory to the binding of withanolides. p53R249S mutation critically disturbed the H-bond network and destabilized the DNA binding site. However, withanolides did not show any selective binding to either this ...Continue Reading

References

May 15, 1997·Nature·Y HauptM Oren
May 15, 1997·Nature·M H KubbutatK H Vousden
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·A N BullockA R Fersht
Oct 9, 1998·Genes & Development·A J Giaccia, M B Kastan
Oct 29, 1998·The Journal of Biological Chemistry·R WadhwaS C Kaul
Apr 17, 1999·Molecular and Cellular Biology·G SelivanovaK G Wiman
Jun 23, 2001·Neoplasia : an International Journal for Oncology Research·S C KaulR Wadhwa
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Assaf FriedlerAlan R Fersht
Mar 5, 2002·Nature Medicine·Vladimir J N BykovGalina Selivanova
Mar 22, 2003·Current Opinion in Cell Biology·Christopher L Brooks, Wei Gu
Apr 3, 2004·Molecular and Cellular Biology·Wan Mui ChanRandy Y C Poon
Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Oct 29, 2004·Nature Reviews. Cancer·Ann M Bode, Zigang Dong
Oct 4, 2005·Journal of Computational Chemistry·David A CaseRobert J Woods
May 3, 2006·The American Journal of Pathology·Charles WalkerBen Low
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Andreas C JoergerAlan R Fersht
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nashi WidodoSunil C Kaul
Apr 24, 2008·Nature Reviews. Molecular Cell Biology·Todd RileyArnold Levine
Jul 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Frank M BoecklerAlan R Fersht
Feb 26, 2010·Cold Spring Harbor Perspectives in Biology·Magali OlivierPierre Hainaut
Dec 18, 2010·International Journal of Cancer. Journal International Du Cancer·Wen-Jing LuJohn M Luk
Dec 25, 2012·Nature Cell Biology·Patricia A J Muller, Karen H Vousden
Jan 15, 2013·The Protein Journal·Shah Md Abdur RaufAkira Miyamoto
Apr 13, 2013·Journal of Computer-aided Molecular Design·G Madhavi SastryWoody Sherman
May 1, 2013·Nucleic Acids Research·Xiangrui LiuAlan R Fersht
Jan 1, 2011·Cancers·Toshinori Ozaki, Akira Nakagawara
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Apr 18, 2014·Nature Reviews. Cancer·Kathryn T BiegingLaura D Attardi
Sep 9, 2017·Cell·Edward R Kastenhuber, Scott W Lowe
Sep 21, 2017·Mutation Research. Reviews in Mutation Research·Olaf MerkelLukas Kenner
Feb 21, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A GreenL B Abrahmsen
Oct 17, 2018·Cancer Chemotherapy and Pharmacology·Akshay BinaykeHarish Chander

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
Assay
flow cytometery

Software Mentioned

Amber
SiteMap
ImageJ
Antechamber
Schrödinger
AxioVision

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.